Home   |  Publications   |   Conferences    |  Join   |   Contact   | Sitemap  
Facebook    Twitter     Linkedin     RSS     Google+    BLOG    You Tube
 

Journal of Bioequivalence & Bioavailability


Open Access
 
ISSN: 0975-0851
 
 
 
HOME » BIOEQUIVALENCE-BIOAVAILABILITY
  |  French Language  |  
 
 
 
 
 
In Association with
 
 

Upcoming Event

 

About the Journal

 

Bioequivalence refers to a statistically equal extent and rate of absorption of two drugs when administrated at the same molar dose whereas Bioavailability is the rate at which the drug appears in the systemic circulation In Vivo. The Journal of Bioequivalence & Bioavailability provides continuously growing literature and research activities on the regulatory requirements, scientific and practical issues, and statistical methodology of the design and analysis of bioequivalence and bioavailability studies.
 
Journal of Bioequivalence & Bioavailability, an academic journal encompasses a wide range of current research disciplines under the scope of the journal which aims to offer a promising platform for the authors to make their valuable contributions towards the journal. In Omics publishing group, the editorial office is dedicated to ensure the peer review process of the manuscripts by the eminent editors and the reviewers to raise the quality of publishing.
 
Journal of Bioequivalence & Bioavailability is among the best open access journals of the Omics group, set out to publish the most comprehensive, relevant and reliable information based on the current research and development in the field of Bioequivalence and Bioavailability. This information can be published in our peer reviewed journal with impact factors as original articles, review articles, case reports, short communications, etc. in the journal which is freely available without any restrictions or any other subscriptions for researchers all over the world with the sole intention directed towards the advancement of the scientific world resulting in the betterment of the society.
flyer image  Impact Factor: 3.6*
  Index Copernicus Value: 5.24
 
 

The journal is maintaining quality by using Editorial Manager System for the review process. Editorial Manager is an online manuscript submission, review and tracking system. Peer review process is carried out by our dignified editorial board members of Bioequivalence & Bioavailability or outside experts. To publish any articles, at least two independent reviewer’s approval followed by the editor’s approval is required. Authors may submit manuscripts and track their progress through the system, hopefully to publication. Reviewers have the facility to download the manuscripts and submit their suggestions to the editor. Editors can manage the whole submission/review/revise/publish process.

OMICS Group cordially invites all the participants across the globe to attend the 5th World Congress on Bioavailabity and Bioequivalence: Pharmaceutical R&D Summit during Sep 29 - Oct 01, 2014 at Baltimore, USA. Bioavailability and bioequivalence World Congress- 2014 is a platform for various people from pharmaceutical backgrounds, HealthCare institutions, Pharmaceutical regulatory agencies, Biotech and Clinical Research organizations.

Submit manuscript at http://www.editorialmanager.com/jbiobio/ or send as an e-mail attachment to the Editorial Office at editor.jbiobio@omicsonline.org

 
*Unofficial 2013 Impact Factor was established by dividing the number of articles published in 2011 and 2012 with the number of times they are cited in 2013 based on Google search and the Scholar Citation Index database. If ‘X’ is the total number of articles published in 2011 and 2012, and ‘Y’ is the number of times these articles were cited in indexed journals during 2013 than, impact factor = X/Y

 
 
 

Recently published articles

Bioequivalence Study of Two 50 mg Desvenlafaxine Extended Release Formulations: A Randomized, Single-Dose, Open-Label, Two Periods, Crossover Study

Vargas M, Villarraga E and Vargas Jba

 
A Validated Stability-indicating Liquid Chromatographic Method for Determination of Cabazitaxel-A Novel Microtubule Inhibitor

Mathrusri Annapurna Mukthinuthalapati, Venkatesh Bukkapatnam and Naga Supriya Grandhi

 
Bioequivalence of a New Generic Formulation of Erlotinib Hydrochloride 150 mg Tablets versus Tarceva in Healthy Volunteers under Fasting Conditions

Dalia Jawhari, Mahmoud Alswisi, Mahmoud Ghannam and Jamil Al Halman

 
Degradation Study of Metronidazole in Active and Different Formulation by UV Spectroscopy

Safila Naveed, Nimra Waheed and Safeena Nazeer

 
Intra Subject Variability of Progesterone 200 mg Soft Capsules in Indian Healthy Adult Postmenopausal Female Subjects under Fasting Conditions

Rajeswara Rao P and Someswara Rao K

 
Therapeutic Management in the Idiopathic Ventricular Fibrillation: Is there Still a Place for Pharmacological Treatment?

Osmar Antonio Centurión

 
Use of Informatics in Identification of Adverse Drug Reactions

Sachin Devi

 
 
 
 
 
 
20082014 OMICS Group - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version